STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive: CML is a prototype of a myeloid neoplasm where a single driver mutant, BCR-ABL1, initiates activation of multiple pro-oncogenic signaling molecules, including STAT5 [24].